Galien week of innovation

Product: NeuroSphere^TM Virtual Clinic

Company: Abbott

Therapeutic Area: Neurology

About the Product:

Approximately 50 million Americans suffer from chronic pain, in addition to millions of others who live with Parkinson’s disease or essential tremor – movement disorders that tend to be neurodegenerative and worsen over time. People with these often debilitating disorders face significant hurdles not only to get diagnosed but also to receive care. NeuroSphere™ Virtual Clinic serves as a first-of-its-kind application in the U.S. that allows a patient to both communicate with a physician directly and remotely receive settings to their neurostimulation devices in real-time regardless of location* and has drastically changed the lives of over 15,000 patients across the country. *Anywhere with a cellular or Wi-Fi connection and sufficiently charged patient controller.

Research team:

• Greg Creek
• Scott DeBates
• Doug Lautner
• Hiren Patel
• Yagna Pathak
• Asish Punnoose
• Jenna Roycraft
• Sonia Santimano
• Sree Thankathuraipandian

Product: Mallya

Company: Biocorp

Therapeutic Area: Internal Medicine

About the Product:

Mallya is an add-on device that turns injection pens into connected devices. It automatically records treatment information (selected dose, date and time of injection). Data are sent in real time to a mobile application thanks to Bluetooth technology to effectively manage diseases such as diabetes, fertility problems, and growth disorders. To be effective, these conditions require careful and precise treatment. However, it can be difficult for patients to accurately report multiple injections and avoid errors or oversights. Mallya is responding to this need with a solution that enhances patient self-management while enabling healthcare professionals to analyze and adjust treatment protocols.

Research team:
Alain MARCOZ - VP Global Innovation Lionel ALDON - VP Product Development Xavier JULIA - VP Industrialization & Project Management Alexia GARIN - VP Quality Assurance & Regulatory affairs

Product: Canvas Dx ASD Diagnostic Aid

Company: Cognoa

About the Product:

Cognoa's breakthrough product, Canvas Dx, is the first and only FDA-authorized autism diagnostic that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias in children 1.5 through 6 years of age.

Canvas Dx creates “instant specialists” by equipping providers with a definitive solution to confidently act on early developmental concerns and make accurate diagnoses in days, not months or years. With Canvas Dx, more families - particularly those in historically under-served populations - will be able to begin critical interventions earlier, rather than wait to see a pediatric specialist and delay progress.

Product: MamaLift, MamaLift Plus, FertiLift, BellaLift

Company: Curio Digital Therapeutics

Therapeutic Area: Gynecology

About the Product:

MamaLift is a digital-forward, mobile application-enabled Cognitive Behavioral Therapy program that is augmented by health coaches and therapists. MamaLift is intended to help women reduce their risk of anxiety or depression during pregnancy or after delivery. For those with higher acuity symptoms, MamaLift Plus, a Class II device, is available. MamaLift Plus delivers neurobehavioral interventions combined with trackers and exercises to support women during the perinatal period. In addition, Curio offers its population health tool, Curio-I. Curio-I leverages AI-powered algorithms to risk-stratify a population of patients and identify 88% of third-trimester women who will go on to develop postpartum depression.

Research team:

• Ana Fonseca, PhD
• Fabiana Monteiro, PhD
• Sid Shankar, MBA

Product: Intellewave device

Company: Intellewave

Therapeutic Area: Internal Medicine

About the Product:

The Stress & Wellness iPhone App is a self-assessment test that takes approximately 4-5 minutes to complete. It consists of a 3–4-minute laying-to-standing test and a 1-2 minute deep breathing exercise. For measurement we utilize the renowned and highly accurate Polar sensor. The test provides information on Sympathetic/Parasympathetic activity levels, as well as an overall physiological status known as the Fitness Score. This implementation aligns with the practical application of the Digital Health concept. The first component of Digital Health involves monitoring parasympathetic function, which is linked to damage of Parasympathetic receptors and serves as a marker for pathophysiological development.

• Alexander Riftine, PhD
• Julia Riftine, MD
  

Product:  Mymee

Company: Mymee

Therapeutic Area: Rheumatology - Orthopedics

About the Product:

Mymee is the first digital care solution proven to help autoimmune and long COVID patients reduce flares and reclaim their health. Autoimmune patients with an inadequate response to prescribed treatment have high sensitivities to their exposome (eg. food, drugs, viruses), which can drive or worsen symptoms. Mymee’s proprietary method of identifying an individual’s exposome triggers has been clinically validated in real world studies, demonstrating statistically significant improvements in joint pain, fatigue, stiffness, brain fog, muscle weakness & other rheumatic symptoms. Mymee’s evidence-based Personalized Trial & Care Program is SOC-2 and HIPAA compliant, and backed by an advisory board of key opinion leaders.

Research team:

• Mette Dyhrberg
• Nicole Bundy
• Millienia Lytle
• Mackenzie de Jesus

Product: NoviGuide

Company: NoviGuide

Therapeutic Area: Internal Medicine

About the Product:

NoviGuide helps clinicians follow guidelines. Our software platform tackles the guideline-following problem from multiple angles. It begins by making it easier to quickly take narrative guidelines and convert them into interactive pathways. The pathways then flow directly into a bedside-ready Point-of-Care application for web or mobile. Usage data is captured at the site level. In our Insights Dashboard, customers can see where clinicians are encountering barriers preventing them from following the guidelines.

Research team:

• Joshua Bress, MD
• Elon Danziger

Product:  FokusRx

Company: Revibe Technologies

Therapeutic Area: Neurology

About the Product:

Revibe Technologies' FokusRx is a groundbreaking digital solution designed to enhance focus and productivity without the necessity of drugs. This innovative wearable platform leverages personalized therapeutic vibrations and cutting-edge AI technology to provide real-time, non-invasive improvements for individuals struggling with attention challenges, without side-effects. FokusRx utilizes smartwatch technology and advanced AI-driven algorithms to monitor attention levels and deliver gentle, customizable reminders to stay on task. With its discreet design, it seamlessly integrates into daily routines without disruption. Users benefit from improved attention, increased productivity, and additional time spent learning. FokusRx empowers individuals to unlock their full potential, making it an invaluable tool for students, professionals, and anyone seeking to optimize their cognitive performance.

Research team:

• Rich Brancaccio
• Chris Guidry
• Dr. Lindsay Ayearst
• Daniel Baggott Zhenzhen Zhang
• Taylor Neal
• Joseph Koziak
  

Product: MammoScreen®

Company: Therapixel

Therapeutic Area: Gynecology

About the Product:

MammoScreen® is a software that helps radiologists with the interpretation of screening mammograms. With MammoScreen, even experienced radiologists improve their performance, feel more confident in their decision, and find more cancers. MammoScreen is an AI-based proficiency tool working alongside radiologists. Its uniquely actionable MammoScreen Score™ allows them to quickly confirm what they suspect and detect what they have missed. They can concentrate their energy on the questionable cases that require further scrutiny, while reassuring women quicker otherwise. Winner of the DREAM Digital Mammography Challenge, the largest competition ever organized in AI for breast imaging. Subscription-based and vendor-neutral, easily fits into existing infrastructure providing non-intrusive zero-click workflow.

Product: ContaCT

Company: Viz.ai

Therapeutic Area: Cardiovascular

About the Product:

Viz.ai pioneered the use of AI algorithms and machine learning to increase the speed of diagnosis and care for a variety of diseases across health systems. The Viz Platform is an intelligent care coordination solution that unifies synchronized care collaboration, high fidelity mobile image viewing, automated workflows and improved visibility at decision-making moments. Viz.ai’s comprehensive AI platform is clinically proven to save time and improve patient outcomes and access to care and is used in more than 1,200 hospitals. Viz.ai’s life science portfolio expands the power of the AI-powered Platform to pharmaceutical and medical device companies who are leaning into digital transformation to bring life-saving therapies to market more efficiently.

Product: XRHealth virtual Clinic

Company: XRHealth

Therapeutic Area: Neurology

About the Product:

XRHealth Telehealth services provide innovative and cutting-edge virtual healthcare solutions that leverage Extended Reality (XR) technologies. With a focus on revolutionizing patient care, XRHealth seamlessly connects patients and healthcare professionals in a virtual environment. Through XR-powered platforms, patients can access personalized treatments for various medical conditions, such as mental health, pain management, occupational and physical rehabilitation, and cognitive training. The platform incorporates immersive experiences, including virtual reality (VR), to enhance engagement and treatment outcomes. XRHealth's secure and user-friendly platform empowers patients to receive remote consultations, monitor progress, and access a wide range of therapeutic exercises and activities from the comfort of their homes.

Research team:

• Maya Bein-Nachal
• Tal Arbel
• Miki Levy

Product: Behavidence App

Company: Behavidence

Therapeutic Area: Neurology

About the Product:

Behavidence utilizes AI to detect and monitor mental health conditions by identifying subtle changes in phone usage patterns. Behavidence now offers AI models for monitoring Depression, Anxiety, Stress, ADHD and PPD. The product has been adopted by health organizations, health technology, commercial and government entities across the globe. In addition to screening and for remote monitoring, Behavidence products can be used to detect comorbidities and as a measurement based outcome to predict relapse and therapeutic efficacy of interventions. It offers absolute user privacy, zero respondent burden and real time feedback.

Research team:

• Roy Cohen
• Dr. Janine Ellenberger
• Dr. Girish Srinivasan
• Soumya Choudhary
• Or Cohen
• Nikita Thomas
• Maria Torounidou
• Usman Nawaz
• Saad Wassem
• Yonit Fehl
• Ela Kliots
• Shapira Monira
• Kaouech Yuosif
• Yakub-Hana Kim
• Preis Nora
• Ginio Haris Iqbal

Product: Butterfly iQ+

Company: Butterfly Network, Inc.

Therapeutic Area: Ultrasound on a Chip technology that makes standard medical imaging screens more accessible and affordable for patients.

About the Product:

Butterfly Network, Inc. reimagined ultrasound by replacing piezoelectric crystal sensors with a single semiconductor chip the size of a postage stamp. Through its Ultrasound-On-Chip™ technology, Butterfly made medical imaging more accessible and affordable than ever before. Its portable, handheld solution, Butterfly iQ+ is powered by intuitive software and artificial intelligence that aims to make point-of-care ultrasound increasingly versatile, efficient, and easy to learn and use. Butterfly is driving a paradigm shift in the standard of care for all patients, everywhere, by improving accuracy, speed, cost efficiency, and excellence of care. The company continues to innovate its proprietary hardware, software, and services to accelerate as a comprehensive clinical assessment solution - one that can become as ubiquitous as the stethoscope and in the pockets of practitioners around the world being used on every patient, every time.

Product: Empatica Health Monitoring Platform

Company: Empatica

Therapeutic Area: Internal Medicine

About the Product:

The Empatica Health Monitoring Platform is an FDA-cleared, modular remote health monitoring solution, that enriches medical research and healthcare practices with real-world health insights collected via wearable sensors. It is a full-stack suite consisting of Empatica’s medical-grade EmbracePlus wearable, software, digital biomarkers, and Cloud. The platform enables the continuous collection, streaming, and storage of physiological signals and digital measures across locations and continents. Already in use in hundreds of studies from leading pharmaceutical companies and research institutions, today’s researchers look to Empatica’s platform to better understand human health and draw scientific conclusions backed by continuous, real-world data.

Research team:

• Matteo Lai
• Simone Tognetti
• Riccardo Sirtori
• Ivan Cenci
• Francesco Corazza
• Rosalind Picard
• Daniele Resnati

Product: Flow, Meditation for modern life

Company: Flow.is

Therapeutic Area: Neurology

About the Product:

Instead of asking people to close their eyes and sit still for an extended period, Flow was founded with an idea of a more accessible and immersive way to reach the benefits of meditation. Flow offers meditation in VR and allows you to escape your work piles, morning stress, or sleepless nights, and access a world of wonder within seconds.

Product: Hyperion

Company: UR Medicine Wilmot Cancer Institute

Therapeutic Area: Internal Medicine

About the Product:

Hyperion is an innovative, scalable, and cost-effective data management platform designed for academic healthcare organizations. It efficiently processes, stores, and validates large volumes of data from multiple sources, such as electronic health records and research data. The platform supports real-time analytics, customizable dashboards, and secure data access, tailored to user roles and needs. By enhancing decision-making, streamlining operations, and facilitating research, Hyperion provides a comprehensive solution to address the complex data challenges faced by physicians, nurses, administrators, and researchers within an academic cancer center.

Research team:

• Eric Snyder
• Lisa Smith
• Scott Cunliffe
• Scott Paoni
• Scott Isaacs
• Erika Ramsdale
• Emily Strong
• Jonathan Conrad
• Anna Brown
• Wallace Wallace
• Kevin Desousa
• Omara Alvelo

Product: Medable Decentralized Clinical Trials Platform

Company: Medable

Therapeutic Area: Internal Medicine

About the Product:

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with innovative technologies. The company’s digital platform streamlines design, recruitment, retention, and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Medable’s software has been named a Leader in the industry by both Everest Group and IDC.

Research team:

• Michelle Longmire
• Tim Smith
• James Sas
• Perry Robinson
• Fer Waigandt

Product: MetaboFlux PrecisionCare (MFPC)

Company: Metalytics

Therapeutic Area & Indication: MFPC will be used for both the diagnosis and treatment of aggressive and chemotherapy-resistant cancers

About the Product:

Metalytics maps the flow of metabolism within a cell in order to identify and overcome metabolic bottlenecks that limit cell productivity. We work with a wide variety of cell lines and organisms used to produce products across life science industries. Our premiere offering, CoreMFA™, goes beyond traditional metabolomics to provide an unparalleled view of cell metabolism. CloneSelectMFA™ and MFALite™ are the first of several SaaS offerings from our new MFAtwin™ platform.  CloneSelectMFA gives clients the unparalleled ability to identify top-performing CHO clones in minutes while only requiring a limited amount of experimental data.  MFALite allows for the visualization of cell metabolism with only a few data inputs and provides AI-driven solutions to optimize culture media conditions and overcome metabolic bottlenecks.

Research team:

Product: One Drop

Company: Endocrinology

Therapeutic Area: Endocrinology

About the Product:

Product: Patientory

Company: Patientory, Inc.

Therapeutic Area & Indication: Internal Medicine

About the Product:

A population health data management and analytics company, Patientory, Inc. is the largest health data marketplace that empowers users to take charge of their health. As a blockchain and HIPAA software application that includes an Enterprise web portal Neith and consumer mobile App, the purpose of Patientory is to securely facilitate and encrypt the transmission of health data while empowering healthcare professionals and patients in storing healthcare data and the ability to monetize that secure data. Through its two decentralized applications, Patientory Inc. provides patients with ownership and insights and enterprises with comprehensive healthcare data intelligence.

Product: The Science 37 Metasite^TM

Company: Science 37

Therapeutic Area: Internal Medicine

About the Product:

Science 37 Holdings, Inc.’s (Nasdaq: SNCE) accelerates clinical research by enabling universal trial access for patients. The Metasite™—a virtual site—enables access to a patient population beyond traditional sites, with flexible participation from the comfort of patient homes, at local community providers, or at a research site when needed. The Metasite is powered by a proprietary platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data.

Research team:

• David Coman, CEO
• Dr. Jonathan Cotliar, Chief Medical Officer
• Darcy Forman, Chief Delivery Officer

Product: AI based Primary Healthcare Operating System

Company: Techmedo

Therapeutic Area: Internal Medicine

About the Product:

Introducing the TECHMEDO Digital Primary Care Operating System, a groundbreaking product that is set to revolutionize healthcare delivery. This innovative system seamlessly integrates virtual care, large language models, advanced data analytics, and patient-centric features to empower healthcare providers and enhance patient outcomes. By offering accessible and convenient care, promoting early detection and prevention, and optimizing resource allocation, the Digital Primary Care Operating System transforms primary care into a comprehensive, efficient, and personalized experience. Join us during the Galien Week of Innovation as we showcase this transformative solution, shaping the future of healthcare and improving the well-being of individuals and communities worldwide

Research team:

• Mr. Zahid Ali Ashraf
• Dr. Pervez Gondal MD
• Mr. Ali Irfan
• Ms. Maryam Hassan
• Mr. Nadeem Mustafa
• Mr. Saflian Haider
• Mr. Andrew AJ Herkert
• Dr. Affan Faiqzada
• Dr. Shafeeq Haider
• Dr. Asif Imam
• Dr. Anne Walker
• Mr. Ghulam Mustafa
• Mr. Salman Saeed
• Ms. Aiza Islam

Product: uMotif eCOA/ePRO and Engagement Platform: First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones

Company: uMotif

Therapeutic Area: Internal  Medicine

About the Product: 

Research team: